BQ talks to Maven investee Microbiosensor

As the Northern Powerhouse Investment Fund (NPIF) celebrates backing £100m of investment across the Northern Powerhouse region, BQ looks back at some of the businesses that are achieving their ambitious growth plans with our support. 

Manchester-based Microbiosensor secured a £700,000 equity investment from NPIF Maven Equity Finance, in a co-investment deal alongside Catapult Cheshire Life Sciences Fund.

Established in 2012, the University of Manchester spin-out company develops disposable point-of-care medical devices for the early diagnosis of microbial infection. The funding has allowed the company to complete the development of its first product, TripleCheck, an infection diagnostic for patients on renal dialysis, and to plan for a multicentre clinical study to validate that product in Q2 2019.  

To view the full article on BQ click here.

The Northern Powerhouse Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.

If your business is in need of finance to help unlock its growth potential, NPIF Maven Equity Finance may be able to help. Contact Maven’s local team today on 0161 233 3500.

Subscribe for email updates

Keep up-to-date with all the latest news and insights from Maven,
including new investments, events and our blog.